financetom
Business
financetom
/
Business
/
COVID-19 fallout: JSW deal to buy Kamalanga Energy put on hold
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
COVID-19 fallout: JSW deal to buy Kamalanga Energy put on hold
May 21, 2020 6:36 AM

The sale of GMR Energy's entire stake in GMR Kamalanga Energy Ltd to JSW Energy has been put on hold on account of outbreak of COVID-19, according to a regulatory filing.

In February, JSW Energy had signed a share purchase agreement to acquire 100 percent of GMR Kamalanga Energy, which owns and operates a 1,050 MW (3x350 MW) thermal power plant in Odisha, for Rs 5,321 crore (subject to working capital and other adjustments).

"The transaction has been put on hold due to the outbreak of the pandemic COVID-19 and nationwide lockdown, and will be revisited once the situation normalises," GMR Infrastructure - the parent company of GMR Energy - said in a filing to BSE on Thursday.

The company said that even in these hard times, with demand falling across the country, the pithead plant of GMR Kamalanga Energy is fully operational, adding that the government announcing series of reforms along with Rs 90,000-crore package to discoms for easing liquidity is a step in the right direction for the power sector.

GMR Kamalanga Energy, a subsidiary of GMR Energy, owns and operates three units of 350 MW capacity at Dhenkanal in Odisha.

The shares of GMR Infrastructure were trading at Rs 17.45 a piece on BSE in morning trade, up 0.87 per cent from their previous close.

First Published:May 21, 2020 3:36 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioNTech buys China's Biotheus to support oncology strategy
BioNTech buys China's Biotheus to support oncology strategy
Nov 13, 2024
Nov 13 (Reuters) - German drugmaker BioNTech has agreed to acquire Chinese biotech company Biotheus to support its oncology strategy and gain full global rights to the bispecific antibody candidate BNT327, it said on Wednesday. BNT327 has been tested in clinical trials with tumour patients, and Biotheus previously held the rights to commercialize it in the Greater China market. Under...
CyberArk Software CFO Josh Siegel to Step Down; Erica Smith Named Successor
CyberArk Software CFO Josh Siegel to Step Down; Erica Smith Named Successor
Nov 13, 2024
07:43 AM EST, 11/13/2024 (MT Newswires) -- CyberArk Software ( CYBR ) said Wednesday that Chief Financial Officer Josh Siegel will step down on Jan. 1, 2025, and Deputy CFO Erica Smith will succeed him as part of a planned succession. Siegel will take on an advisory role and Smith will become part of the CyberArk executive team, according to...
Rivian shares surge on $5.8 bln Volkswagen investment in JV
Rivian shares surge on $5.8 bln Volkswagen investment in JV
Nov 13, 2024
Nov 13 (Reuters) - Shares of Rivian jumped over 13% in premarket trading Wednesday after the electric vehicle maker announced a $5.8 billion investment from German automaker Volkswagen as part of their joint venture. The investment boost comes at a crucial time for Rivian, which aims to cut costs, achieve profitability, and launch its smaller, more affordable R2 SUV to...
Spirit Airlines Reportedly Considering Bankruptcy Protection After Frontier Deal Fails
Spirit Airlines Reportedly Considering Bankruptcy Protection After Frontier Deal Fails
Nov 13, 2024
07:28 AM EST, 11/13/2024 (MT Newswires) -- Spirit Airlines ( SAVE ) may seek bankruptcy protection after merger discussions with Frontier Group Holdings ( ULCC ) fell apart, multiple media reports said late Tuesday. Spirit said in its filing late Tuesday that it was unable to submit its Q3 earnings report, citing efforts to restructure obligations have diverted time and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved